Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Skin Neoplasms × reolysin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 6 Neoplasm Metastasis 4 Breast Neoplasms 4 Neoplasms 3 Melanoma 3 Carcinoma 3 Squamous Cell Carcinoma of Head and Neck 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Glioma 2 Fallopian Tube Neoplasms 2 Unspecified Childhood Solid Tumor, Protocol Specific 1 Triple Negative Breast Neoplasms 1 Skin Neoplasms 1 Sarcoma, Synovial 1 Sarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Ras-mutated Metastatic Colorectal Cancer 1 Prostatic Neoplasms 1 Osteosarcoma 1 Oligodendroglioma 1 Neuroectodermal Tumors, Primitive 1 Medulloblastoma 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Glioblastoma 1 Fibrosarcoma 1 Diffuse Intrinsic Pontine Glioma 1 Colorectal Neoplasms 1

Interventions

pembrolizumab 23 Nivolumab 20 aldesleukin 19 Cyclophosphamide 18 Ipilimumab 16 Interleukin-2 15 fludarabine 14 fludarabine phosphate 12 cemiplimab 11 Radiotherapy 7 Biopsy 7 dabrafenib 6 Surveys and Questionnaires 6 Fluorouracil 6 Dacarbazine 6 trametinib 5 binimetinib 5 Vemurafenib 5 Surgical Procedures, Operative 5 Radiation 5 Blood Specimen Collection 5 Aminolevulinic Acid 5 encorafenib 4 Temozolomide 4 Sirolimus 4 Photochemotherapy 4 Educational Status 4 sonidegib 3 montanide ISA 51 3 avelumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03282188 2018-05-04

REO13 Melanoma With of Without GM-CSF

University of Leeds

Phase 1/2 Withdrawn

Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡